Day: May 8, 2023

BILLERICA, Mass., May 08, 2023 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 2023. First Quarter 2023 SummaryTotal revenue of $12.8 million, a decrease of 17% year-over-year on a reported and constant currency basis. Product revenue of $12.7 million, a decrease of 15% year-over-year on a reported basis and 14% on a constant currency basis. Conformis hip system revenue of $0.8 million, an increase of 3% year-over-year. Cash and cash equivalents of $37.8 million as of March 31, 2023.    Three months ended March 31, Increase/(decrease)($, in thousands)     2023     2022   $ Change % Change % Change          (as reported) (constant currency)United...

Gross margin improved 10 p.p. to 43% in 1Q23 compared to 1Q22 SÃO PAULO, Brazil, May 08, 2023 (GLOBE NEWSWIRE) — Semantix, Inc. (NASDAQ: STIX), a leading Latin American end-to-end data and enterprise AI platform provider, today announced its financial results for the quarter ended March 31, 2023. “Since increasing focus on our core proprietary SaaS only one quarter ago, we are pleased with the vigor and traction we are seeing in prioritizing higher-quality proprietary SaaS revenue, with accompanying relevant improvements in our gross margin profile, reflecting our culture of always seeking efficiency in our business,” said Leonardo Santos, CEO and Founder of Semantix. “I remain confident in our ability to deliver sustainable growth this year while making progress delivering against key initiatives.” First Quarter 2023 Financial...

First quarter software and solutions revenue increased 42% year over year Subscription-based revenue represented 56% of total revenue in the first quarter DENVER, May 08, 2023 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced 67% revenue growth in the first quarter. For the period ending March 31, 2023, the Company reported revenue of $2.0 million, compared with $1.2 million for the fourth quarter of 2022 and $2.0 million for the first quarter of 2022. Software and solutions represented 64% of total revenue as the Company continues to grow its commercial business with recurring subscriptions and high margins. Intermap’s advanced technology and automation are driving scale and operating leverage, resulting...

Auvelity® 1Q 2023 net product sales of $15.7 million Total 1Q 2023 net product sales of $28.6 million Total 1Q 2023 revenue of $94.6 million, including Sunosi® ex-U.S. license agreement upfront payment Company to host conference call today at 8:00 AM Eastern NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today reported financial results for the first quarter ended March 31, 2023. “The first quarter of 2023 was another important milestone for Axsome as it marked the first full quarter of launch for Auvelity. Based on the performance in the quarter, we are pleased that our marketed products are making a difference in the lives of a growing number of patients with...

BELO HORIZONTE-MG, Brazil, May 08, 2023 (GLOBE NEWSWIRE) — Inter&Co, Inc (Inter), (NASDAQ: INTR | B3: INBR32), the premier Super App which provides financial and digital commerce services to more than 26 million customers, today reported financial results for its first quarter ended March 31, 2023. The full earnings release has been made available on the Company’s Investor Relations website at ri.bancointer.com.br. João Vitor Menin, CEO of Inter&Co stated: “Following an incredible 2022, we’ve seen a strong start of 2023. I’m happy to say that we are harvesting profitable results from our solid foundations. Our focus on delighting our clients while delivering operational excellence has been paramount. We had a significant level of new active client adds, reaching the impressive mark of 1 million in one quarter. Additionally,...

Continued Strong Topline GrowthStrong operating performance drove Adjusted EBITDA improvementRe-affirms net sales & Adjusted EBITDA guidance SECAUCUS, N.J., May 08, 2023 (GLOBE NEWSWIRE) — Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today reported financial results for its first quarter ended March 31, 2023.  First Quarter 2023 Financial Highlights Compared to Prior Year PeriodNet sales of $167.5 million, an increase of 26.7% Net loss of $24.8 million, compared with prior year net loss of $17.5 million Adjusted EBITDA of $3.0 million, compared to prior year of $(0.3) million.1“We are off to a very strong start to 2023 behind our recently launched Fresh Future plan. That plan promised renewed focus on improving profitability while continuing to drive strong growth. And our first quarter results demonstrate...